Appendix 1: Acceptable intakes established for N-nitrosamines
Appendix 1: Acceptable intakes established for N-nitrosamines
Appendix 1: Acceptable intakes established for N-nitrosamines
Overview of comments received on the draft qualification opinion for Simcyp Simulator
Qualification opinion for Simcyp Simulator
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 19, Status: Authorised
List of EU Medicines Regulatory Agency Organisation with single and multiple LOC IDs for Product Management Services (PMS) data enrichment - Chapter 2 Annex III
PSUSA/00000832/202411
Highlight report - 14th meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines
IRIS guide to registration and RPIs
Human medicines European public assessment report (EPAR): Trepulmix, treprostinil, Date of authorisation: 03/04/2020, Revision: 8, Status: Authorised
Paediatric-use marketing authorisations